Theraworx Class Action Lawsuit Claims Product Doesn’t Provide Muscle Pain Relief

Following a recommendation by the BBB’s National Advertising Division, Avadim faces a class action lawsuit challenging claims that Theraworx provides muscle pain relief.

Plaintiff Luz Sanchez says he and other consumers were misled by Avadim Health’s representations that Theraworx Muscle Cramp & Spasm Relief Foam can provide muscle pain relief. According to Sanchez, these misleading marketing claims caused consumers to overpay for the product.

Theraworx is a topical pain relief product. Unlike other pain relief products such as Icy Hot or Biofreeze, Theraworx does not contain active ingredients such as capsaicin, trolamine salicylate, or lidocaine. Instead, Theraworx Muscle Cramp & Spasm Relief uses magnesium sulfate as its active ingredient.

Magnesium occurs naturally in the body and plays an important role in muscles and nerves. As a medication, magnesium sulfate has several uses depending on its application.

As an injection, magnesium sulfate can be used to treat low magnesium levels and prevent seizures in pregnant women with certain health conditions. As an oral medication, the chemical can be used as a laxative by increasing the water in the intestines. Topically, magnesium sulfate can be used as an epsom salt soak for body aches.

In Theraworx Muscle Cramp & Spasm Relief Foam, Avadim Health claims that magnesium sulfate can be used for “Muscle Cramp and Spasm Relief” and that the product “Prevents Cramps & Spasms,” “Releases Muscle Tightness,” and “Reduces Muscle Soreness.” Despite these representations, Sanchez claims that consumers such as himself have not received the benefits they were promised.

Sanchez notes that FDA guidance on external analgesic – or pain relief – products stresses that these products should be indicated for relieving only minor pain and providing only temporary relief. Despite these recommendations, Avadim allegedly markets their Theraworx products as able to provide a higher level of pain relief than other similar products.

“Defendant’s Product emphasizes its ability to provide pain relief of a more significant and enduring type than [other topical analgesics], even though its active ingredient, magnesium sulfate, has not been reviewed or found to be generally recognized as safe or effective by the FDA to diagnose, treat, cure, prevent or mitigate any diseases or conditions,” Sanchez contends in his Theraworx muscle pain relief class action lawsuit.

Theraworx marketing claims are reportedly promised to be “clinically proven.” However, Avadim has allegedly failed to conduct the double-blind randomized studies required to validate these claims. Sanchez argues that the FDA requires this careful research in order to support pain relief claims.

Although Avadim Health has offered five studies to support their claims, Sanchez says these studies are insufficient since they focused on leg cramps and spasms associated with restless leg syndrome and nocturnal leg cramps.

According to Sanchez, none of the studies cited by Avadim support the Theraworx claims surrounding “muscle soreness,” “post-cramp soreness,” “foot cramps,” “muscle tightness” or “leg cramps associated with many important, commonly prescribed medications.”

Even the studies that have been done were allegedly insufficient as they were not blinded, had inadequate sample sizes, and had inappropriate time periods.

“There is no genuine scientific research and no scientifically reliable studies that support the extraordinary claims that the Product can provide the effects indicated,” Sanchez maintains.

Sanchez argues that he and a Class of New York Theraworx purchasers were financially injured by Avadim’s conduct because they were deceived into purchasing the products or paying a higher price based on promises of muscle pain relief. The plaintiff seeks injunctive relief, restitution, disgorgement, and monetary damages for these injuries.

This is not the first time that Theraworx marketing claims were challenged. In fact, the Theraworx muscle pain relief class action lawsuit was filed shortly after the Better Business Bureau’s National Advertising Division (NAD) determined that Avadim failed to provide reasonable support for their health-related claims.

According to the NAD, the advertiser should discontinue their “unsupported health-related, product effectiveness, endorsement, and superiority claims.” A Sanofi subsidiary responsible for topical pain relief products such as Icy Hot also challenged the validity of Theraworx health claims.

Did you purchase Theraworx products? Did the product fail to provide you with muscle pain relief? Share your experiences in the comment section below.

Sanchez and the proposed Class are represented by Spencer Sheehan of Sheehan & Associates PC.

The Theraworx Muscle Pain Relief Class Action Lawsuit is Luz Sanchez v. Avadim Health Inc., Case No. 1:20-cv-10272, in the U.S. District Court for the Southern District of New York.

Read About More Class Action Lawsuits & Class Action Settlements:

• Little Remedies Pain Reliever Not ‘Specially Formulated’ for Babies, Class Action Lawsuit Says
• Curamin Pain Relief Supplements Don’t Work, Class Action Lawsuit Alleges
• Can You Request a Female Uber Driver?
• What is an Alternative to Zantac?